116 related articles for article (PubMed ID: 10667582)
1. Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma.
Livant DL; Brabec RK; Pienta KJ; Allen DL; Kurachi K; Markwart S; Upadhyaya A
Cancer Res; 2000 Jan; 60(2):309-20. PubMed ID: 10667582
[TBL] [Abstract][Full Text] [Related]
2. Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.
Yao H; Veine DM; Zeng ZZ; Fay KS; Staszewski ED; Livant DL
Clin Exp Metastasis; 2010 Mar; 27(3):173-84. PubMed ID: 20339907
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.
van Golen KL; Bao L; Brewer GJ; Pienta KJ; Kamradt JM; Livant DL; Merajver SD
Neoplasia; 2002; 4(5):373-9. PubMed ID: 12192595
[TBL] [Abstract][Full Text] [Related]
4. A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.
Veine DM; Yao H; Stafford DR; Fay KS; Livant DL
Clin Exp Metastasis; 2014 Apr; 31(4):379-93. PubMed ID: 24464034
[TBL] [Abstract][Full Text] [Related]
5. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.
Yao H; Veine DM; Fay KS; Staszewski ED; Zeng ZZ; Livant DL
Breast Cancer Res Treat; 2011 Jan; 125(2):363-75. PubMed ID: 20300829
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Yao H; Veine DM; Livant DL
Breast Cancer Res Treat; 2016 Jun; 157(3):489-501. PubMed ID: 27255534
[TBL] [Abstract][Full Text] [Related]
7. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
8. Integrin fibronectin receptors in matrix metalloproteinase-1-dependent invasion by breast cancer and mammary epithelial cells.
Jia Y; Zeng ZZ; Markwart SM; Rockwood KF; Ignatoski KM; Ethier SP; Livant DL
Cancer Res; 2004 Dec; 64(23):8674-81. PubMed ID: 15574776
[TBL] [Abstract][Full Text] [Related]
9. Adhesion and invasion potential of rat prostatic cancer cells: correlation with metastatic potential.
Cooper CR; Donald C; Emmett N; Harris-Hooker S; Cooke DB
Invasion Metastasis; 1993; 13(4):178-84. PubMed ID: 8034439
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).
Iwamoto Y; Nomizu M; Yamada Y; Ito Y; Tanaka K; Sugioka Y
Br J Cancer; 1996 Mar; 73(5):589-95. PubMed ID: 8605091
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor invasion and metastasis by peptidic mimetics of Arg-Gly Asp (RGD) derived from the cell recognition site of fibronectin.
Fujii H; Nishikawa N; Komazawa H; Orikasa A; Ono M; Itoh I; Murata J; Azuma I; Saiki I
Oncol Res; 1996; 8(9):333-42. PubMed ID: 8979267
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
14. The effect of amiloride on the metastatic properties of prostate cancer in the Dunning rat model.
Pilat MJ; Lehr JE; Quigley MM; Pienta KJ
Oncol Rep; 1998; 5(4):889-92. PubMed ID: 9625839
[TBL] [Abstract][Full Text] [Related]
15. (-)-Gossypol reduces invasiveness in metastatic prostate cancer cells.
Huang YW; Wang LS; Dowd MK; Wan PJ; Lin YC
Anticancer Res; 2009 Jun; 29(6):2179-88. PubMed ID: 19528479
[TBL] [Abstract][Full Text] [Related]
16. Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.
Schirner M; Herzberg F; Schmidt R; Streit M; Schöning M; Hummel M; Kaufmann C; Thiel E; Kreuser ED
Clin Exp Metastasis; 1998 Jul; 16(5):427-35. PubMed ID: 10091938
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
18. Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation.
Saiki I; Koike C; Obata A; Fujii H; Murata J; Kiso M; Hasegawa A; Komazawa H; Tsukada H; Azuma I; Okada S; Oku N
Int J Cancer; 1996 Mar; 65(6):833-9. PubMed ID: 8631600
[TBL] [Abstract][Full Text] [Related]
19. Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.
Strömvall K; Lundholm M; Thysell E; Bergh A; Halin Bergström S
PLoS One; 2017; 12(10):e0187086. PubMed ID: 29073272
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).
Geldof AA; Rao BR
Anticancer Res; 1988; 8(6):1335-9. PubMed ID: 3218966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
